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Introduction 
 
Src-family kinases (SFKs), a family of non-receptor-type tyrosine kinases, are 
expressed in a variety of cell types, tissues and organs, including epithelial, 
hematopoietic and neuronal cells, and play critical roles in cell signalling at the 
cytoplasmic side of the plasma membrane (Brown & Cooper, 1996, Thomas & 
Brugge, 1997). SFKs include at least eight highly homologous members: c-Src, 
Lyn, c-Yes, Fyn, c-Fgr, Hck, Lck, and Blk. They are composed of: (i) a N-terminal 
Src homology (SH) 4 domain that contains lipid modification sites, (ii) a unique 
domain, (iii) a SH3 domain, which binds to proline-rich sequences, (iv) a SH2 
domain that binds to a phosphotyrosine-containing motif, (v) a catalytic domain, 
and (vi) a C-terminal negative regulatory region (Brown & Cooper, 1996, Thomas 
& Brugge, 1997). In addition, v-Src is an oncogenic mutant of the cellular proto-
oncogene c-Src owing to the lack of the C-terminal negative regulatory tyrosine 
residue (Martin, 2001, Frame, 2002). 
All members of the SFKs, in which the initiating methionine (Met) is removed 
by methionine aminopeptidase, are cotranslationally myristoylated at glycine 
(Gly)-2 in the amino-terminal SH4 domain and, with the exception of c-Src and 
Blk, are also posttranslationally palmitoylated at cysteine (Cys)-3, Cys-5 or Cys-6 
(Fig. 1). Lyn, a mono-myristoylated and mono-palmitoylated SFK, contains Gly-2 
for myristoylation and Cys-3 for palmitoylation in the SH4 domain, both of which 
are necessary for membrane anchorage of Lyn (Resh, 1994, Resh 1999). Our 
laboratory showed that Lyn is exocytosed toward the plasma membrane via the 
Golgi region along the secretory pathway following its biosynthesis in the 
cytoplasm (Kasahara et al., 2004, Matsuda et al., 2006, Ikeda et al., 2009, Sato et 
al., 2009, Obata et al., 2010). In addition, palmitoylation of Lyn and Fyn at Cys-3 
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is important for their membrane localization and trafficking (Fig. 2) (Resh, 1994, 
Resh, 1999, Sato et al., 2009, Shenoy-Scaria et al., 1994, Kasahara et al 2007a, 
Kasahara et al., 2007b). 
Although SFKs have crucial roles in cell signalling at the cytoplasmic side of 
the plasma membrane (Hubbard. & Till., 2000, Hunter. 2009), the roles of Src-
mediated tyrosine phosphorylation in the nucleus have not been fully understood. 
Our laboratory has shown that at least four members of the SFKs, c-Src, Lyn, Fyn 
and c-Yes, are endogenously present in nuclei of HeLa cells and hematopoietic 
cells (Yamaguchi et al., 2001, Kuga et al., 2007, Ikeda et al., 2008, Takahashi et 
al., 2009). Recently, we uncovered that KRAB-associated protein 1 (KAP1) is 
tyrosine-phosphorylated by nuclear tyrosine kinases, including c-Src, and that 
tyrosine phosphorylation of KAP1 inhibits the association of KAP1 and 
heterochromatin protein 1α (HP1α) with heterochromatin (Kubota et al., 2013). 
Our laboratory also revealed that tyrosine phosphorylation of A-kinase anchoring 
protein 8 (AKAP8) by nuclear tyrosine kinases, including c-Src, dissociates 
AKAP8 from chromatin and the nuclear matrix (Kubota et al., 2015). These results 
demonstrate the significance of nucleus-localized SFKs in dynamic chromatin 
regulation. Furthermore, SFKs have been reported to regulate cell division (Roche 
et al., 1995, Tominaga et al., 2000, Ng et al., 2005). Our laboratory then found the 
roles of SFKs in cytokinesis abscission, spindle assembly and spindle orientation 
(Yamaguchi et al., 2001, Kasahara et al., 2007c, Nakayama et al., 2012, Okamoto 
et al., 2016). Despite the importance of membrane anchorage of SFKs, the role for 
their lipid modifications in cell division is largely unknown. 
In my dissertation, I showed that the inability of SFKs to be modified with 
lipids is responsible for induction of chromosome missegregation, such as anaphase 
chromosome bridging and chromosome lagging. I further showed that the tyrosine 
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kinase activity of non-lipid-modified SFKs appearing from early prophase is 
deeply involved in induction of chromosome missegregation. These findings raise 
the intriguing possibility that membrane anchorage of SFKs via lipid modification 
may protect normal cell division from non-membrane-bound Src-induced 
chromosome missegregation. 
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Material and Methods 
 
Plasmids, transfection, and cells 
Lyn-wt (wild-type Lyn), Lyn(G2A/C3A) [glycine at position 2 (glycine-2) to 
alanine, cysteine at position 3 (cysteine-3) to alanine], Lyn(G2A/C3A)-KD 
[Lyn(G2A/C3A/K275A)] (glycine-2 to alanine, cysteine-3 to alanine; kinase-dead, 
lysine at position 275 to alanine), Lyn(C3S) (cysteine-3 to serine), NLS-Lyn 
(nuclear localization signal-tagged Lyn), and NLS-Lyn(KD) [NLS-Lyn(kinase-
dead)] (nuclear localization signal-tagged Lyn; kinase-dead, lysine at position 275 
to arginine, tyrosine at position 508 to phenylalanine) were constructed from cDNA 
coding for human wild-type Lyn (Yamanashi et al., 1987) (provided by T. 
Yamamoto), as described previously (Kasahara et al., 2004, Sato et al., 2009, 
Kasahara et al., 2007a, Kuga et al., 2007, Ikeda et al., 2008, Kubota et al., 2013). 
For inducible protein expression, all constructs were subcloned into the 
pcDNA4/TO vector (Invitrogen) (Nakayama et al., 2009). pcDNA4/TO/FH-NLS-
Lyn-wt (FLAG- and HA-tagged, nuclear localization signal-tagged, wild-type Lyn) 
and pcDNA4/TO/FH-NLS-Lyn(KD) [FH-tagged NLS-Lyn(kinase-dead)] were 
generated as follows. The FH-NLS-Lyn-wt fragment was created by PCR using 
Lyn-wt or Lyn(KD) as a template with the sense primer  5’-
ATAGAATTCCGTTGAACCATGGACTACAAGGACGACGATGACAAGC-3’ 
and the antisense primer 5’-
GGAGCGGCCGCCCTGTGCTCTSSGGCTGCTGCTG-3’. The FH-NLS-
Lyn(KD) fragment was designed by PCR using the sense primer 5’- 
ATAGAATTCCGTTGAACCATGGACTACAAGGACGACGATGACAAGC-3’ 
and the antisense primer 5’-
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GGAGCGGCCGCCCTGTGCTCTSSGGCTGCTGCTGGAATTGCCCTTCCGT
-3’. The EcoRI–NotI fragment of the PCR product was introduced into the EcoRI–
NotI sites of pcDNA4/TOneo (Nakayama et al., 2009). Green fluorescent protein 
(GFP) was obtained from the pEGFP-C1 vector (Clontech Laboratories, Inc.) and 
subcloned into pcDNA4/TO (Kuga et al., 2008). v-Src-wt and v-Src(K295M) 
(kinase-dead, lysine at position 295 to methionine) (Ohnishi et al., 2001) (provided 
by H. Ohnishi) were subcloned into pcDNA4/TO (Soeda et al., 2013). c-Src-HA 
and c-Src(G2A)-HA were constructed from pcDNA3/c-Src-HA (Fessart et al., 
2005) (provided by S.A. Laporte). pcDNA4/TO/c-Src-HA was constructed as 
described previously (Nakayama et al., 2012). The glycine to alanine mutation at 
position 2 in c-Src(G2A)-HA was created by site-directed mutagenesis with c-Src-
HA as a template using the sense primer 5’-
GTGGAATTCCGACCACCATGGCTAGCAACAAGAGCAAGCCCAAGGATG
C-3’  and  the  antisense primer  5’-
CTTGGGCTTGCTCTTGTTGCTAGCCATGGTGGTCGGAATTCCACCACAC
-3’. The EcoRI–Xba1 fragment of the PCR product was introduced into the EcoRI–
Xba1 sites of pcDNA4/TO/neo (Nakayama et al., 2012). Transient and stable 
transfection was performed using 25-kDa linear polyethylenimine (Polysciences, 
Inc.) (Fukumoto et al., 2010). To establish stable cell lines that inducibly express 
either NLS-Lyn or NLS-Lyn(KD), HeLa S3 cells (Japanese Collection of Research 
Bioresources, Osaka, Japan) were co-transfected with the pCAG vector encoding 
tetracycline repressor (TR) (Kuga et al., 2008) and a plasmid encoding the 
hygromycin resistance gene, and selected in 200 µg/ml hygromycin (HeLa 
S3/NLS-Lyn, HeLa S3/NLS-Lyn(KD)). Cells stably expressing TR (HeLa S3/TR) 
were transfected with pcDNA4/TO/NLS-Lyn or pcDNA4/TO/NLS-Lyn(KD), and 
cell clones inducibly expressing NLS-Lyn or NLS-Lyn(KD) were selected in 500 
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µg/ml G418. 
 
Antibodies 
All antibodies used in this study are shown in table 1 
 
Immunofluorescence microscopy 
Immunofluorescence staining was performed as described (Obata et al., 2010, 
Soeda et al., 2013, Yamaguchi et al., 1995). In brief, cells were fixed with 4% 
paraformaldehyde in Dulbecco's phosphate-buffered saline (D-PBS) for 20 min, 
and permeabilized with 0.2% Triton X-100 in D-PBS for 5 min. Moreover, fixed 
cells were blocked with 3% bovine serum albumin in D-PBS containing 0.1% 
saponin, and then sequentially incubated with a primary and a secondary antibody 
for 1 hr each. DNA was stained with 20 µg/ml propidium iodide or 20 nM TO-
PRO-3 (Molecular Probes) for 30 min after treatment with 200 µg/ml RNase A. 
Confocal and Nomarski differential-interference-contrast (DIC) images were 
obtained using a Fluoview Fv500 laser scanning microscope with 40 × 0.95 N.A. 
objective (Olympus, Tokyo, Japan). Composite figures were prepared using 
Photoshop 13.0 and Illustrator 16.0 software (Adobe).  
 
Flow cytometry 
Flow cytometric analysis was performed as described (Nakayama et al., 2012, 
Hasegawa et al., 2014, Kubota et al., 2014). In brief, cells detached by 
trypsinization were fixed in 4% paraformaldehyde for 1 hr, permeabilized with 
70% ethanol for at least 1 hr at -30oC, and blocked with 3% bovine serum albumin 
in D-PBS containing 0.1% saponin for 30 min at room temperature. After washing 
with D-PBS containing 0.1% Tween 20, cells were co-immunostained with anti-
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H3pS10 and anti-cyclin B1 antibodies for 1 hr at room temperature, then stained 
with secondary antibodies. DNA staining was done by propidium iodide after 
treatment with RNase A. A minimum of 5,000 cells per sample was analyzed by 
flow cytometry using a Guava easyCyte (Millipore) equipped with a 488-nm laser 
and a 640-nm laser using Flowing Software version 2.5.0 (Perttu Terho, Centre for 
Biotechnology, Turku, Finland). Cell debris was excluded by gating on forward 
scatter and pulse-width profiles.  
 
Western blotting 
Cells were lysed in SDS-sample buffer, and cell lysates were subjected to SDS-
PAGE and transferred onto polyvinylidene difluoride membranes (Millipore). To 
detect tyrosine phosphorylation of proteins, cell lysates were prepared with SDS-
sample buffer containing 10 mM sodium orthovanadate, 20 mM ß-
glycerophosphate, and 50 mM NaF. Immunodetection was performed by enhanced 
chemiluminescence and examined using an image analyzer ChemiDoc XRSplus 
(Bio-Rad) as reported previously (Obata et al., 2010, Nakayama et al., 2009). 
Sequential reprobing of membranes with various antibodies was performed after 
the removal of antibodies from the membranes or inactivation of HRP by 0.1% 
NaN3, according to the manufacturer’s instructions.  
 
Cell cycle synchronization 
HeLa S3/NLS-Lyn or HeLa S3/NLS-Lyn(KD) cells were arrested in G1/S phase 
with 4 mM thymidine for 24 hr. After 6 hr release from G1/S-phase arrest in 
thymidine-free fresh medium, the cells were incubated for further 6 hr in medium 
with or without 1 µg/ml doxycycline , a tetracycline derivative, for inducible 
expression. Cells were treated with the Src inhibitor PP2 (10 µM) and doxycycline 
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from the last 3 hr incubation (In my main publication, Fig. 2d). HeLa S3/TR cells 
were treated with 4 mM thymidine for 24 hr and arrested at G1/S phase (In my 
main publication, Fig. 2a). Subsequently, the cells were released for 4 hr. To 
synchronize cells in G2 phase, cells were treated with the cyclin-dependent kinase 
1 (Cdk1) inhibitor RO-3306 (9 µM) (Calbiochem) for 8 hr with/without 
doxycycline (1 ng/ml~2 µg/ml). Cells arrested at the G2/M boundary were washed 
with D-PBS containing Ca2+ and Mg2+ [D-PBS(+)], released into M phase, and 
fixed at 1 hr from the release (Hasegawa et al., 2014). Cells were treated with 10 
µM PP2 for the last 1hr incubation of RO-3306 and doxycycline (In my main 
publication, Fig. 4). Double thymidine block was performed as described 
previously (Nakayama et al., 2009, Kubota et al., 2014). Cells treated with 4 mM 
thymidine for 15 hr were incubated in complete medium without thymidine for 9 
hr, and the cells were further treated with 4 mM thymidine for 15 hr (In my main 
publication Fig. 1). 
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Results 
Section 1 
Inducible Src-dependent inhibition of M-phase entry  
Recently, we generated HCT116 and HeLa S3 cell lines stably expressing 
tetracycline-inducible v-Src (HCT116/v-Src and HeLa S3/v-Src), and showed that 
expression of v-Src inhibits cell proliferation in a kinase activity-dependent manner 
(Soeda et al., 2013). Also, we showed that inducible v-Src gives rise to a significant 
increase in chromosome bridge formation (Soeda et al., 2013). To analyze whether 
expression of v-Src affected cell cycle progression from G2 phase to M phase, 
HeLa S3/v-Src cells that were arrested at G1/S phase were further synchronized at 
the G2/M boundary in the presence of the cyclin-dependent kinase 1 (Cdk1) 
inhibitor RO-3306, and v-Src was induced by the addition of doxycycline in G2 
phase. After release from cell cycle arrest at the G2/M boundary, cells were 
analyzed for cyclin B1 expression (a G2 and M phase marker) and phosphorylation 
of histone H3 at serine-10 (H3pS10, a mitotic marker) (In my main publication, 
Fig. 1a). Flow cytometric analysis showed that v-Src expression in G2 phase 
decreased the number of M-phase cells, thereby giving rise to inhibition of the onset 
of mitosis (In my main publication, Fig. 1b). However, inducible expression of a 
kinase-dead v-Src mutant [v-Src(K295M)] did not affect the onset of mitosis (In 
my main publication, Fig. 1c). Considering that activation of c-Src is found during 
M phase (Chackalaparampil, & Shalloway, 1988, Morgan et al., 1989), these 
results suggest that v-Src expression during G2 and M phases profoundly affects 
the onset of mitosis in a kinase activity-dependent manner, which may link to 
chromosome missegregation. 
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Section2 
Induction of chromosome missegregation by NLS-Lyn expression. 
v-Src, the viral oncogene product, lacks the negative regulatory tyrosine residue 
at the C-terminus and is a constitutively active form of its cellular counterpart c-
Src (Martin, 2001). Our laboratory has shown that SFKs play important roles in 
mitosis (Kasahara et al., 2007b, Kuga et al., 2007, Kasahara et al., 2007c, 
Nakayama et al., 2012, Okamoto et al., 2016, Matsui et al., 2012). In particular, 
mitotic activation of c-Src, c-Yes, Lyn and Fyn, which are all co-expressed in HeLa 
cells, takes place downstream of Cdk1 activation during M phase (Kuga et al., 
2007). Furthermore, SFKs, albeit small fractions, are definitely present in the 
nucleus (Kuga et al., 2007, Ikeda et al., 2008, Takahashi et al., 2009). To examine 
the effect of nuclear localized Lyn, a member of the Src family, on progression of 
cells from G2 phase into M phase, Lyn was tagged with a nuclear localization 
signal at the amino-terminus (NLS-Lyn) and the tetracycline-inducible expression 
of NLS-Lyn or a kinase-dead mutant of NLS-Lyn [NLS-Lyn(KD)] was generated 
in HeLa S3 cells [HeLa S3/NLS-Lyn and HeLa S3/NLS-Lyn(KD) cell lines]. 
Western blotting analysis showed that NLS-Lyn and NLS-Lyn(KD) were inducibly 
expressed by doxycycline addition and that autophosphorylation, which leads to 
activation of the kinase activity, was detected on NLS-Lyn but not NLS-Lyn(KD) 
(In my main publication, Fig. 2a), confirming that NLS-Lyn(KD) is deficient in the 
kinase activity. Intriguingly, upon induction of NLS-Lyn by doxycycline treatment, 
HeLa S3/NLS-Lyn cells showed the increased number of cells exhibiting anaphase 
lagging chromosomes and chromosome bridges (In my main publication, Fig. 2b, 
2c), indicative of chromosomal instability and characteristics of chromosome 
missegregation (Gisselsson, 2003, Hoffelde et al., 2004, Burrell et al., 2013). In 
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contrast to NLS-Lyn, NLS-Lyn(KD) expression did not increase the frequency of 
lagging chromosomes and chromosome bridges (In my main publication, Fig. 2c). 
To further examine the role of the kinase activity of SFKs in induction of 
chromosome missegregation, I used the Src kinase inhibitor PP2. In fact, treatment 
of NLS-Lyn-expressing cells with PP2 inhibited the induction of chromosome 
missegregation (In my main publication, Fig. 2d). These results suggest that 
induction of chromosome missegregation is dependent on the kinase activity of 
NLS-Lyn. 
Then, I examined the period of time when the kinase activity of NLS-Lyn acts 
on the induction of chromosome missegregation. Since the appearance of H3pS10 
begins in early prophase at the onset of mitotic chromosome condensation (Sauvé 
et al., 1999), cells were found to enter prophase 11~12 hr after release from 
thymidine-synchronized G1/S arrest (In my main publication, Fig. 2e). The kinase 
activity of doxycycline -induced NLS-Lyn was inhibited by the treatment with PP2 
for (ii) 6 hr, (iii) the last 3 hr, or (iv) the last 1 hr (In my main publication, Fig. 2f). 
Intriguingly, NLS-Lyn-induced chromosome missegregation was inhibited in any 
of these treatment times, indicating that treatment with PP2 for the last 1 hr was 
sufficient for inhibiting the induction of chromosome missegregation (In my main 
publication, Fig. 2f; see also in my main publication, Fig. 2e). These results suggest 
that nuclear tyrosine kinase activities in prophase with the onset of chromosome 
condensation may be critical for exacerbation of chromosome missegregation. 
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Section 3 
Effect of lipid modifications of c-Src and Lyn on induction of chromosome 
missegregation. 
Newly synthesized Lyn, in which the initiating methionine is removed by 
methionine aminopeptidase during translation, is myristoylated at glycine-2 by N-
myristoyl transferase and subsequently palmitoylated at cysteine-3 by palmitoyl 
acyltransferase, and these lipid modifications are essential for membrane 
association of SFKs, including Lyn (Resh, 1994, Resh, 1999, Sato et al., 2009). I 
used Lyn(G2A/C3A), a non-lipid modified Lyn by replacing glycine-2 and 
cysteine-3 with alanine residues, because the double alanine mutation of glycine-2 
and cysteine-3 completely blocks membrane anchorage of Lyn, thereby increasing 
the amount of Lyn within the nucleus (Ikeda et al., 2008). I then examined whether 
chromosome missegregation was induced by the expression of Lyn(G2A/C3A) in 
place of NLS-Lyn. To synchronize cells in M phase, HeLa S3/TR cells transiently 
expressing GFP (green fluorescent protein as a vector control), wild-type Lyn 
(Lyn-wt), or Lyn(G2A/C3A) were arrested at the G2/M boundary by treatment 
with RO-3306 for 8 hr and released into drug-free medium for 60 min to enter M 
phase (In my main publication, Fig. 3a-3c). Notably, the number of cells exhibiting 
chromosome missegregation was signiﬁcantly increased upon expression of 
Lyn(G2A/C3A) compared to that of Lyn-wt or GFP (In my main publication, Fig. 
3b, 3c). Western blotting analysis showed that strong autophosphorylation of 
Lyn(G2A/C3A) were detected during M phase (In my main publication, Fig. 3d). 
Considering that attachment of the NLS sequence to the amino-terminus of Lyn not 
only promotes nuclear localization of Lyn but also blocks its amino-terminal lipid 
modifications, these results suggest that, like NLS-Lyn, a lack of lipid 
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modifications of Lyn significantly increases the frequency of chromosome 
missegregation. 
To examine the role of the kinase activity of Lyn(G2A/C3A) in induction of 
chromosome missegregation, we used Lyn(G2A/C3A)-KD (kinase-dead) and PP2. 
HeLa S3/TR cells transiently transfected with Lyn(G2A/C3A) were treated with 
doxycycline for inducible expression. Western blotting analysis showed that 
doxycycline -induced Lyn(G2A/C3A) was autophosphorylated in M phase (In my 
main publication, Fig. 3d) and that PP2 treatment decreased tyrosine 
phosphorylation levels of cellular proteins to some extent (In my main publication, 
Supplementary Figs S2b and S3). Treatment of Lyn(G2A/C3A)-expressing cells 
with PP2 significantly inhibited Lyn(G2A/C3A)-induced chromosome 
missegregation (In my main publication, Fig. 3e). Then, we confirmed by Western 
blotting analysis that Lyn(G2A/C3A)-KD is devoid of the kinase activity (In my 
main publication, Fig. 3d; Supplementary Fig.S2). It is of quite interest to note that 
expression of Lyn(G2A/C3A)-KD strongly inhibited chromosome missegregation 
(In my main publication, Fig. 3e), assuming that Lyn(G2A/C3A)-KD may act as a 
dominant-negative mutant form toward endogenous Lyn that fails in myristoylation 
and palmitoylation. On the other hand, Lyn(C3S), which can be myristoylated but 
not palmitoylated, did not exacerbate chromosome missegregation levels compared 
with Lyn(G2A/C3A). Furthermore, Lyn(G2A/C3A) was delocalized throughout 
the inside of a cell, whereas Lyn-wt was seen restrictedly at the plasma membrane 
in M phase (In my main publication, Fig. 3b). However, as the level of 
Lyn(G2A/C3A)-mediated tyrosine phosphorylation was not the highest among Lyn 
mutants (In my main publication, Supplementary Fig. S4), we consider that the 
levels of the kinase activity of Lyn mutants are not correlated with those of 
chromosome missegregation. These results suggest that non-membrane-bound Lyn, 
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such as Lyn(G2A/C3A) and NLS-Lyn, is associated with the induction of 
chromosome missegregation during M phase. 
Whereas Lyn-wt is in general doubly myristoylated and palmitoylated, wild-
type c-Src (c-Src-wt) is myristoylated but not palmitoylated because of the absence 
of the palmitoylation site in the entire amino acid sequence of c-Src (Resh, 1994, 
Resh, 1999, Sato et al., 2009). To examine whether the lack of myristoylation of c-
Src resulted in exacerbating chromosome missegregation, we prepared c-Src(G2A), 
which lacks the myristoylation site resulting in production of non-lipid-modified c-
Src. HeLa S3/TR cells transiently transfected with c-Src or c-Src(G2A) were 
synchronized as shown in Fig. 5a and compared the levels of chromosome 
missegregation between c-Src and c-Src(G2A) expressions. Expression of c-
Src(G2A) increased the frequency of chromosome missegregation at a similar 
extent to that of Lyn(G2A/C3A) (In my main publication, Fig. 4a,b). Notably, c-
Src(G2A) was delocalized to the nucleus and the cytoplasm in early prophase and 
to the cytoplasm in metaphase and anaphase, whereas c-Src-wt was largely 
localized to punctate structures (In my main publication, Fig. 4c,d). Considering 
that the level of c-Src(G2A)-mediated tyrosine phosphorylation was comparable to 
that of c-Src-wt (In my main publication, Supplementary Fig. S5), these results 
suggest that a lack of lipid modifications of Src-family kinases results in 
exacerbating chromosome missegregation owing to their delocalization. In other 
words, their membrane anchorage through lipid modifications from prophase to 
anaphase plays a protective role in induction of chromosome missegregation (Fig. 
3). 
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Discussion 
 
In this dissertation, I show that the defect in lipid modifications of Lyn and c-
Src is significantly involved in induction of chromosome missegregation, such as 
formation of lagging chromosomes and anaphase chromosome bridges, in a kinase 
activity-dependent manner. Time course analysis with PP2 shows that the kinase 
activity of non-lipid-modified, non-membrane-bound Src during M phase is critical 
for giving rise to chromosome missegregation. 
Our laboratory has shown that the way of lipid modifications of Src-family 
kinases plays an important role in their intracellular membrane trafficking and 
nuclear translocation (Kasahara et al., 2004, Sato et al., 2009, Kasahara et al., 2007a, 
Ikeda et al., 2008). Lyn’s myristoylation at glycine-2 and its subsequent 
palmitoylation at cysteine-3 and c-Src’s myristoylation at glycine-2 are needed for 
their association with the plasma membrane (Resh, 1994, Resh, 1999). In addition, 
Lyn mutants lacking the lipid modification sites are accumulated within the nucleus, 
suggesting that deletion of the lipid modification sites of Lyn enhances the 
accumulation of Lyn within the nucleus (Ikeda et al., 2008). Mutation of glycine-2 
within Gα subunits, despite the preservation of cysteine-3, was reported to prevent 
not only myristoylation but also palmitoylation (Mumby et al., 1994). However, 
the double alanine mutation of glycine-2 and cysteine-3 on Lyn fully ensures 
inhibition of its membrane anchoring, thereby increasing the amounts of nuclear 
localization of Lyn. Like Lyn(G2A/C3A), c-Src(G2A) is non-lipid-modified c-Src 
and is accumulated in the nucleus because wild-type c-Src has a mono-
myristoylation site at glycine-2 but not any palmitoylation sites (In my main 
publication, Fig. 4). Notably, previous study showed that approximately 16% of 
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newly synthesized c-Src and v-Src are normally not myristoylated and fail to 
anchor to the plasma membrane and organelle membranes (Buss et al., 1985). 
Indeed, our laboratory showed that Src-family members, c-Src, c-Yes, Lyn and Fyn, 
are endogenously present in the nucleus (Yamaguchi et al., 2001, Ikeda et al., 2008, 
Takahashi et al., 2009). These results suggest that the failure in lipid modifications 
of endogenous SFKs may result in their nuclear accumulation. 
Not only c-Src but also Lyn, Fyn and c-Yes are all activated upon M phase 
entry by Cdk1-cyclin B1 and/or PTPα (Kuga et al., 2007, Roche et al., 1995, 
Chackalaparampil, & Shalloway, 1988, Morgan et al., 1989, Zheng, & Shalloway, 
2001). Considering that expression of Lyn(G2A/C3A) results in the increased 
levels of chromosome missegregation similar to that of NLS-Lyn, which is 
incapable of being lipid modified owing to the addition of an NLS sequence at the 
N-terminus of Lyn (In my main publication, Figs. 2c and 3e), I assume that 
induction of chromosome missegregation may be attributable to the presence of the 
kinase activity in the nucleoplasm during prophase and in the cytoplasm after 
nuclear envelope breakdown. Provided that anaphase chromosome bridging is 
caused by pre-mitotic defects, such as DNA double-strand breaks (Gisselsson, 
2008) or mitotic defects in securin or cohesin degradation (Chestukhin et al., 2003, 
Sotillo et al., 2007), the presence of non-lipid-modified, non-membrane-bound Src-
family kinases during M phase may bring about chromosome missegregation 
through their increased accessibility to mitotic chromosome-associated proteins. 
Chromosomal instability, defined as frequent changes in chromosome structure 
and number, is increasingly appreciated as a key component of tumorigenesis 
(Jallepalli, & Lengauer, 2001, Schvartzman et al., 2010). The process of 
chromosomal instability involves chromosome missegregation at anaphase in some 
or most instances (Jallepalli et al., 2001). Anaphase chromosome bridges are 
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associated with chromosome missegregation and have occasionally been observed 
in colorectal neoplasia and in sarcomas (Montgomery et al., 2003). Furthermore, 
anaphase chromosome bridges have been strongly linked to chromosomal 
instability in human tumor samples (Gisselsson, 2008, Montgomery et al., 2003, 
Fouladi et al., 2000) and tumorigenesis in mice (Rudolph et al., 2001). There is a 
strong correlation between multipolar mitoses and anaphase bridges, and the 
induction of dicentric chromosomes by gamma irradiation and telomerase 
inhibition leads to an elevated frequency of multipolar mitotic spindles, suggesting 
that multipolarity can result from polyploidization triggered by anaphase bridges. 
Moreover, anaphase bridges can arise from a variety of causes, including telomere 
dysfunction, cleavage defect of securin or cohesion (Chestukhin et al., 2003, Sotillo 
et al., 2007), or decatenation failure. Given that an excess amount of non-lipid-
modified SFKs impairs correct chromosome segregation, lipid modifications of 
SFKs may be physically confined to their proper membrane-associated localization 
during mitosis, leading to prevent chromosome missegregation. Thus, a limited 
level of tyrosine phosphorylation during mitosis by non-membrane-bound SFKs 
may be important for proper processing of chromosome segregation. 
In conclusion, I show that mitotic expression of non-lipid-modified SFKs 
significantly induces chromosome missegregation. Membrane association of SFKs 
plays a protective role against chromosome missegregation. Further studies will 
help us to understand the mechanism of Src-induced chromosome missegregation. 
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Table 1 all antibodies used in this study 
 
 
 
Table 1 
 
 
 
 
Antibody
anti-Lyn clone 9
anti-Lyn H-6
Type
Mouse monoclonal IgG
Mouse monoclonal IgG
anti-βactin 13E5 Rabbit monoclonal IgG Cell Signaling Technology
anti-actin C4 Mouse monoclonal IgG Millipore
Provider
Wako chemicals
Santa Cruz Biotechnology
anti-Src #327 Mouse monoclonal IgG Calbiochem
anti-Src[pY416] Rabbit polyclonal IgG Cell Signaling Technology
anti-H3pS10 clone 6G3 Mouse monoclonal IgG Cell Signaling Technology
α-tubulin MCA78G Rat monoclonal IgG Serotec
anti-cyclin B1 H433 Rabbit polyclonal IgG Santa Cruz Biotechnology
anti-cyclin B1 V152 Mouse monoclonal IgG Cell Signaling Technology
anti-rat IgG Horseradish peroxidase-F(ab')2 fragments GE healthcare
anti-mouse IgG Alexa488 donkey Invitrogen
anti-mouse IgG Horseradish peroxidase-F(ab')2 fragments GE healthcare
anti-rabbit IgG Horseradish peroxidase-F(ab')2 fragments GE healthcare
anti-phosphoyrosine 4G10 Mouse monoclonal IgG Update Biotechnology Inc.
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Fig. 1. Lipid modification of Src-family kinases 
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Fig. 2. Traffic of Src-family kinases 
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Fig. 3. Graphical Abstract of this study 
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